Post reperfusion syndrome during liver transplantation: From pathophysiology to therapy and preventive strategies.
暂无分享,去创建一个
[1] Sung-Moon Jeong,et al. Postreperfusion syndrome during liver transplantation , 2015, Korean journal of anesthesiology.
[2] Pedro M. Baptista,et al. Emerging concepts in liver graft preservation. , 2015, World journal of gastroenterology.
[3] J. Henriksen,et al. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects. , 2014, World journal of gastroenterology.
[4] E. Caglayan,et al. Cirrhotic cardiomyopathy: a cardiologist's perspective. , 2014, World journal of gastroenterology.
[5] Felipe Lobato da Silva Costa,et al. Combined remote ischemic perconditioning and local postconditioning on liver ischemia-reperfusion injury. , 2014, The Journal of surgical research.
[6] E. Pretto,et al. Hemodynamic recovery following postreperfusion syndrome in liver transplantation. , 2014, Journal of cardiothoracic and vascular anesthesia.
[7] W-C Lee,et al. Ischemic reperfusion injury-induced oxidative stress and pro-inflammatory mediators in liver transplantation recipients. , 2014, Transplantation proceedings.
[8] R. Speich,et al. Inflammatory cytokines in pulmonary hypertension , 2014, Respiratory Research.
[9] K. Kalimeris,et al. Global Consequences of Liver Ischemia/Reperfusion Injury , 2014, Oxidative medicine and cellular longevity.
[10] N. Fayed,et al. Goal directed preemptive ephedrine attenuates the reperfusion syndrome during adult living donor liver transplantation , 2014 .
[11] J. García-Valdecasas,et al. Stroke Volume Response to Liver Graft Reperfusion Stress in Cirrhotic Patients , 2014, World Journal of Surgery.
[12] L. Harsányi,et al. Remote ischemic perconditioning protects the liver from ischemia-reperfusion injury. , 2013, The Journal of surgical research.
[13] T. Hibi,et al. Crystalloid flush with backward unclamping may decrease post‐reperfusion cardiac arrest and improve short‐term graft function when compared to portal blood flush with forward unclamping during liver transplantation , 2013, Clinical transplantation.
[14] Hyun Sik Chung,et al. Effects of magnesium pretreatment on the levels of T helper cytokines and on the severity of reperfusion syndrome in patients undergoing living donor liver transplantation. , 2013, Magnesium research.
[15] R. Cohen,et al. Sympathetic withdrawal is associated with hypotension after hepatic reperfusion , 2013, Clinical Autonomic Research.
[16] A. Mastro,et al. Association between plasma cyclic guanosine monophosphate levels and hemodynamic instability during liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] Hyung‐Chul Lee,et al. Epinephrine and phenylephrine pretreatments for preventing postreperfusion syndrome during adult liver transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] Haitao Xu,et al. Evaluation of the right ventricular ejection fraction during classic orthotopic liver transplantation without venovenous bypass , 2012, Clinical transplantation.
[19] H. Kim,et al. Incidence and predictors of post‐reperfusion syndrome in living donor liver transplantation , 2012, Clinical transplantation.
[20] Johnny C. Hong,et al. Regulated hepatic reperfusion mitigates ischemia-reperfusion injury and improves survival after prolonged liver warm ischemia: a pilot study on a novel concept of organ resuscitation in a large animal model. , 2012, Journal of the American College of Surgeons.
[21] H. Zhang,et al. Postreperfusion syndrome during orthotopic liver transplantation: a single-center experience. , 2012, Hepatobiliary & pancreatic diseases international : HBPD INT.
[22] M. Krawczyk,et al. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. , 2011, Annals of transplantation.
[23] H. Ryu,et al. Nafamostat Mesilate Attenuates Postreperfusion Syndrome during Liver Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[24] E. Pretto,et al. The effect of methylene blue during orthotopic liver transplantation on post reperfusion syndrome and postoperative graft function , 2011, Journal of hepato-biliary-pancreatic sciences.
[25] A. Güemes,et al. Celsior Versus University of Wisconsin Preserving Solutions for Liver Transplantation: Postreperfusion Syndrome and Outcome of a 5-Year Prospective Randomized Controlled Study , 2011, World Journal of Surgery.
[26] A. Mastro,et al. Release of cytokines and hemodynamic instability during the reperfusion of a liver graft , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[27] E. Pretto,et al. Body surface area index predicts outcome in orthotopic liver transplantation , 2011, Journal of hepato-biliary-pancreatic sciences.
[28] M. A. Sahmeddini,et al. Hypotension after reperfusion in liver transplantation: histidine-tryptophan-ketoglutarate versus University of Wisconsin solution. , 2010, Progress in transplantation.
[29] S. Parsa,et al. Post-reperfusion Syndrome and Outcome Variables after Orthotopic Liver Transplantation , 2010, International journal of organ transplantation medicine.
[30] E. Bernardi,et al. Hyperdynamic circulation in acute liver failure: reperfusion syndrome and outcome following liver transplantation. , 2010, Transplantation proceedings.
[31] R. J. Paneque,et al. Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation , 2010 .
[32] M. Ramsay,et al. Postreperfusion syndrome during liver transplantation for cirrhosis: Outcome and predictors , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[33] M. Gwak,et al. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than University of Wisconsin solution during the reperfusion period in living donor liver transplantation. , 2008, Transplantation proceedings.
[34] J. Bermejo,et al. Cardiac Dysfunction During Liver Transplantation: Incidence and Preoperative Predictors , 2008, Transplantation.
[35] A. Marcos,et al. The impact of postreperfusion syndrome on short‐term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[36] K. Gurusamy,et al. Ischaemic preconditioning for liver transplantation. , 2008, The Cochrane database of systematic reviews.
[37] M. D. de Moura,et al. Elevated nitric oxide and 3',5' cyclic guanosine monophosphate levels in patients with alcoholic cirrhosis. , 2008, World journal of gastroenterology.
[38] L. Grande,et al. Ischemic Pre‐conditioning in Deceased Donor Liver Transplantation: A Prospective Randomized Clinical Trial , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[39] I. Konstantinov,et al. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning. , 2007, American journal of physiology. Heart and circulatory physiology.
[40] J. Figueras,et al. Hemodynamic profile and tissular oxygenation in orthotopic liver transplantation: Influence of hepatic artery or portal vein revascularization of the graft , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[41] G. Ercolani,et al. Effect of ischemic preconditioning in whole liver transplantation from deceased donors. A pilot study , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[42] B. Gridelli,et al. Comparison of two different techniques of reperfusion in adult orthotopic liver transplantation , 2006, Clinical transplantation.
[43] S. Fuggle,et al. Ischemic Preconditioning of Cadaver Donor Livers Protects Allografts following Transplantation , 2006, Transplantation.
[44] P. Hayes,et al. Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites , 2005, Gut.
[45] H. Bismuth,et al. Effects of 10 Minutes of Ischemic Preconditioning of the Cadaveric Liver on the Graft's Preservation and Function: The Ying and the Yang , 2005, Annals of surgery.
[46] J. Skurnick,et al. Ischemic preconditioning in deceased donor liver transplantation: A prospective randomized clinical trial of safety and efficacy , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[47] B. Pollwein,et al. Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. , 2004, British journal of anaesthesia.
[48] X. Gu,et al. Effect of cold-ischemia time on nuclear factor-kappaB activation and inflammatory response in graft after orthotopic liver transplantation in rats. , 2004, World journal of gastroenterology.
[49] M. Bellamy,et al. Complement membrane attack complex and hemodynamic changes during human orthotopic liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[50] R. Busuttil,et al. The utility of marginal donors in liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[51] Y. Tokat,et al. Causes of postreperfusion syndrome in living or cadaveric donor liver transplantations. , 2003, Transplantation proceedings.
[52] José A Fernández,et al. Activation of protein C during reperfusion in clinical liver transplantation , 2003, Transplantation.
[53] J. Findlay,et al. Aprotinin reduces vasoactive medication use during adult liver transplantation. , 2003, Journal of clinical anesthesia.
[54] J. Fung,et al. Activation of the lipopolysaccharide signaling pathway in hepatic transplantation preservation injury12 , 2002, Transplantation.
[55] M. Bellamy,et al. The Effect of Methylene Blue on the Hemodynamic Changes During Ischemia Reperfusion Injury in Orthotopic Liver Transplantation , 2002, Anesthesia and analgesia.
[56] A. Nanashima,et al. Analysis of postrevascularization syndrome after orthotopic liver transplantation: the experience of an Australian liver transplantation center. , 2001, Journal of hepato-biliary-pancreatic surgery.
[57] A. Sheil,et al. Postreperfusion syndrome in orthotopic liver transplantation. , 2000, Transplantation proceedings.
[58] E. Jaurrieta,et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. , 2000 .
[59] H. Putter,et al. Reduced Need for Vasopressors in Patients Receiving Aprotinin during Orthotopic Liver Transplantation , 2000, Anesthesiology.
[60] L. Lindgren,et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study , 2000, The Lancet.
[61] P. Parrilla,et al. Changes in serum potassium during reperfusion in liver transplantation. , 1999, Transplantation proceedings.
[62] P. Parrilla,et al. Atropine prophylaxis of the postreperfusion syndrome in liver transplantation. , 1999, Transplantation proceedings.
[63] P. Parrilla,et al. Effect of reperfusion on right ventriculoarterial coupling in liver transplantation. , 1999, Transplantation proceedings.
[64] P. Parrilla,et al. Influence of surgical technique on postreperfusion syndrome during liver transplantation. , 1999, Transplantation proceedings.
[65] M. Bellamy,et al. Changes in inflammatory mediators during orthotopic liver transplantation. , 1997, British journal of anaesthesia.
[66] M. Csete,et al. Randomized controlled trial to evaluate flush and reperfusion techniques in liver transplantation. , 1997, Transplantation.
[67] M. Vigil,et al. Response to Clamping of the Inferior Vena Cava as a Factor for Predicting Postreperfusion Syndrome During Liver Transplantation , 1997, Anesthesia and analgesia.
[68] K. Tan,et al. Improved haemodynamic stability with administration of aprotinin during orthotopic liver transplantation. , 1995, British journal of anaesthesia.
[69] N. Heaton,et al. Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation. , 1995, British journal of anaesthesia.
[70] S. Blanot,et al. Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation. , 1995, Transplantation.
[71] G. Klintmalm,et al. Activation of the plasma contact system and hemodynamic changes after graft revascularization in liver transplantation. , 1995, Transplantation.
[72] O. Stenqvist,et al. COMPLEMENT SYSTEM ACTIVATION DURING ORTHOTOPIC LIVER TRANSPLANTATION IN MAN: Indications of Peroperative Complement System Activation in the Gut , 1994, Transplantation.
[73] S. Blanot,et al. Circulating endotoxins during orthotopic liver transplantation and post-reperfusion syndrome , 1993, The Lancet.
[74] M. Pinsky,et al. Right Ventricular Function During Orthotopic Liver Transplantation , 1993, Anesthesia and analgesia.
[75] P. Albaladéjo,et al. The failure of venovenous bypass to prevent graft liver postreperfusion syndrome. , 1992, Transplantation.
[76] M. Pinsky,et al. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. , 1987, Transplantation proceedings.
[77] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[78] S. M. Zhu,et al. Epsilon-aminocaproic Acid Improves Postrecirculation Hemodynamics by Reducing Intraliver Activated Protein C Consumption in Orthotopic Liver Transplantation , 2013, World Journal of Surgery.
[79] E. Bernardi,et al. Hyperdynamic circulation in cirrhosis: predictive factors and outcome following liver transplantation. , 2013, Minerva anestesiologica.
[80] R. Jiménez Paneque,et al. Rapid and homogeneous reperfusion as a risk factor for postreperfusion syndrome during orthotopic liver transplantation. , 2010, Revista brasileira de anestesiologia.
[81] M. Adham,et al. Hemodynamic profiles during piggyback liver grafts using arterial or portal revascularization. , 2000, Journal of the American College of Surgeons.